The endocannabinoid system (ECS) is vital in maintaining emotional balance, stress regulation, and reward processing. Chronic substance use disrupts this system, altering the function of cannabinoid receptors and the production of endocannabinoids. For example, excessive cannabis use desensitizes the CB1 receptor, leading to reduced natural reward responses and increased cravings. Similarly, other substances indirectly affect the ECS by impairing its interaction with neurotransmitter systems. This dysregulation contributes to withdrawal symptoms, heightened stress sensitivity, and difficulty sustaining sobriety. Emerging therapies aim to restore ECS function using receptor modulators, dietary changes, and physical activities that promote endocannabinoid balance. Understanding the ECS’s role in addiction provides a promising direction for personalized treatments that target the biological underpinnings of dependency. Such interventions can improve emotional stability, reduce relapse rates, and support long-term recovery.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Genetic decoupling and global regulatory failure in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : An unusual perspective for understanding and preventing bulimia relapse: Unhealthy sibling loyalty
Karen Gail Lewis, Private Practice, United States